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Abstract 
 This study compared the effects of centrally and peripherally administered 
oxytocin (OT) on HPA axis activity and the presence of both stress-induced active and 
passive behaviors in female guinea pig pups (Cavia porcellus) after 180-min of isolation . 
In Experiment 1, one dose of oxytocin (10µg/.2ml) was injected subcutaneously into the 
periphery. Plasma cortisol levels were reduced after 180-min of isolation and two passive 
behaviors, eye-closure and crouch, were reduced as well with the administration of 
oxytocin.  In Experiment 2, two different doses (10µg/.2ml and 20µg/.2ml) were injected 
into the periphery with no significant results.  In Experiment 3 one dose of oxytocin 
(1µg/5µl) was infused centrally.  Plasma cortisol levels were marginally reduced after 30-
min of isolation.  Both the active and passive behaviors were unchanged.   
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1 
Introduction 
 
 
Oxytocin is a neuropeptide hormone synthesized in the magnocellular neurons of 
the paraventricular (PVN) and supraoptic (SON) nuclei of the hypothalamus.  One of the 
major peptides produced in the hypothalamus, this peptide is secreted by the posterior 
pituitary gland.  Oxytocin has an extensive range of physiological effects produced 
through two separate systems: the peripheral and the central oxytocinergic systems (Ring, 
Malberg, Potestio, Ping, Boikess, Luo et al, 2006).  The difference between the two is 
based on their distinct anatomy, functionality and sites of release and action (Ring, et al, 
2006). Peripherally, oxytocin is best known for its hormonal role. In mammals, it is 
responsible for stimulating the smooth muscle of the uterus to initiate contractions during 
the birthing process and promoting lactation thereafter in the myoepithelial cells of the 
breast.  Centrally, oxytocin can act as a neurotransmitter/neuromodulator and control 
some behavioral and physiological CNS parameters. This peptide is thought to influence 
various aspects of maternal (Numan & Insel, 2003), affiliative (Insel & Shapiro, 1992), 
and sexual behavior (Argiolas & Gessa, 1991). Physiologically, it may be able to 
suppress or initiate the release of various peptides also produced within the hypothalamus 
(Suh, Liu, Rasmussen, Gibbs, Steinberg & Yen, 1986). 
Determining the influence of both central and peripheral oxytocin action is the 
blood brain barrier (BBB).  This barrier’s limited permeability discourages the passing of 
numerous substances such as many drugs and endogenous chemicals.   Oxytocin, being 
non-steroid and water soluble, is carried freely within the blood; still, it is a peptide and 
therefore has limited ability to cross the BBB (~0.1% systemic oxytocin enters the brain; 
Jones & Robinson, 1982).  However, there is evidence that suggests the BBB allows for 
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interaction between the two oxytocinergic systems. Research has shown that peripheral 
injections of oxytocin can mirror effects seen with central administration of this peptide.  
One such example is found in Mongolian gerbils where affiliation between monogamous 
females and their partners was increased by subcutaneous injections of oxytocin (Razzoli, 
Cushing, Carter &Valsecchi, 2003).  With a short half life (only 4-5 minutes) and an 
unknown pathway of action in the periphery, oxytocin’s prolonged effects remain unclear 
(Uvnäs-Moberg, 1998).  Perhaps, it is crossing a weak area of the blood brain barrier (the 
circumventricular regions) in tiny, yet sufficient amounts or influencing the release or 
action of other compounds which, in turn, produce persistent CNS activity. 
Central effects of oxytocin 
In sheep, centrally administered oxytocin can significantly increase the frequency 
of most maternal behaviors (low-pitch bleats, sniffing, licking, and 
approaching/following the lamb; Kendrick, Keverne & Baldwin, 1987).  Sheep are a 
useful model of bonding because unlike many other animals, ewes show highly selective 
maternal behavior only with their own lamb (Lim & Young, 2006).   However, with 
vagino-cervical stimulation, a process that increases the release of oxytocin measured in 
cerebrospinal fluid and in the brain using microdialysis (Kendrick, Keverne, 
Baldwin & Sharman, 1986), acceptance of an unfamiliar lamb can be induced even 
following the ewe’s bonding with her own lamb (Kendrick, Lévy & Keverne, 1991).  The 
vagino-cervical stimulation mimics that of parturition, which appears to naturally cause 
the increase in oxytocin and subsequent acceptance of young. Oxytocin injected 
intracerebroventricularly (ICV) can, alone, induce acceptance of an unfamiliar lamb even 
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in non-pregnant ewes (Kendrick et al., 1987). Therefore, oxytocin plays a significant role 
in the bonding of the mother with her offspring. 
 One study demonstrated the role of oxytocin in partner preferences for both 
males and females in the monogamous prairie vole.  Central administration of this 
peptide caused both males and females to exhibit increased social contact and significant 
preference for the familiar partner (Cho, DeVries, Williams & Carter, 1999).  Though 
mating is typically required for formation of the monogamous pair bond, this bond forms 
even in the absence of mating with oxytocin administration (Cho et al., 1999; Williams, 
Carter& Insel, 1992). Further, formation of the pair bond has been shown to be blocked 
with the ICV infusion of oxytocin receptor antagonists even after extended mating bouts 
(Cho et al., 1999; Williams, Insel, Harbaugh & Carter, 1994; Winslow, Hastings, Carter, 
Harbaugh & Insel, 1993). This research provides clear evidence indicating that oxytocin 
is essential for social bonding under some conditions.  
 Possible reward role of oxytocin 
Oxytocin has been found to play a key role in several prosocial behaviors. 
Examples include maternal behavior in sheep, affiliative behavior in several species such 
as sheep and rodents, and sexual behavior in prairie voles. Secretion of this peptide is 
thought to be induced through quiet physical contact with another animal (Carter, 1998). 
Oxytocin administration has been shown to inhibit the rise in circulating glucocorticoid 
levels; much like the presence of an attachment figure is able to do (Windle, Shanks, 
Lightman & Ingram, 1997). Therefore, with rodents, it has been hypothesized that 
maternal presence or contact induces oxytocin release in the young and, in turn, is 
rewarding to the pup (Nelson & Panksepp, 1996). In that study, infant rats that received 
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central administration of oxytocin tended to spend less time in contact with or near, their 
mother. The authors suggest that stimulation of oxytocin receptors reduced the 
motivation for, and the maintenance of, social contact (Nelson & Panksepp, 1996). These 
findings suggest that oxytocin contributes to the rewarding properties of social interaction 
for the pup and may help account for why social interaction is extremely important for 
young.  Rewarding effects of positive experiences can become conditioned to neutral 
cues, implying that maternal presence alone, without physical contact, might induce 
oxytocin release. Indeed, though oxytocin is most likely released endogenously in the pup 
during the infant-mother attachment process via somatosensory stimulation, its release 
also has been shown to be elicited by nonnoxious stimuli such as warm temperature and 
odors, stimuli that the mother typically provides (Uvnäs-Moberg, 1998).  All of these 
stimuli are believed to be rewarding to the pup and promote the animal’s attachment to its 
mother. 
Oxytocin and stress-related effects    
Oxytocin appears to play a key role in reducing stress. Of particular relevance 
here, oxytocin has been found to reduce the activity of the hypothalamic-pituitary-adrenal 
(HPA) axis and behavioral signs of anxiety. The HPA axis plays a critical role in the 
body’s response to stress. Its state of activation is often taken to indicate whether the 
body is experiencing some degree of stress. When activated by stressors, the PVN of the 
hypothalamus releases corticotropin releasing factor (CRF) which in turn activates the 
pituitary gland to release adrenocorticotropin hormone (ACTH).  ACTH is transported to 
the adrenal gland where it initiates the release of glucocorticoids (primarily cortisol or 
corticosterone depending on the species) from the adrenal cortex.  Cortisol enhances the 
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physiological response to stress, be it physical (e.g. electric shock, tissue damage) or 
psychological (uncertainty, novelty, or separation from attachment figure).  The time 
course of plasma cortisol elevation varies greatly in length depending on the severity and 
duration of the stressor(s). Return of HPA activity to basal levels is facilitated by 
negative feedback mechanisms by which cortisol acts at central sites and the pituitary to 
inhibit further release of CRF and ACTH. 
Central neuropeptides, including oxytocin, have been implicated in the control of 
the HPA axis. Prairie voles, when treated with oxytocin both peripherally and centrally, 
show reduced HPA activity (Carter, 1998). Experimental studies in other animals have 
shown that ICV oxytocin inhibits the stress-induced activation of the HPA axis 
(Neumann, Krömer, Toschi & Ebner, 2000; Uvnäs-Moberg, Ahlenius, Hillegaart 
& Alster, 1994; Uvnäs-Moberg, Bjökstrand, Hillegaart & Ahlenius, 1999; Windle et al, 
1997).   This also appears to occur in humans: in lactating women, a suppression of HPA 
activity has been observed if breast-feeding starts 30-60 min before exposure to a stressor 
(Altemus, Deuster, Galliven, Carter & Gold, 1995; Altemus, Redwine, Leong, Frye, 
Porges & Carter, 2001; Heinrichs, Meinlschmidt, Neumann, Wagner, Kirschbaum, Ehlert 
et al., 2001; Heinrichs, Neumann & Ehlert, 2002). Oxytocin’s ability to reduce HPA 
activity may be due to the presence of both oxytocin and CRF containing neurons in the 
PVN.  Oxytocin, somehow, either by blocking receptors or the actual production of CRF 
inhibits the release of CRF from the PVN, which, in turn suppresses HPA activity (Suh et 
al, 1986). 
Oxytocin can produce anxiolytic-like effects; central and peripheral 
administration of oxytocin has been shown to reduce anxiety-like behavior in female rats 
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and mice (Bale, Davis, Auger, Dorsa & McCarthy, 2001; McCarthy, McDonald, Brooks 
& Goldman, 1996; Windle et al, 1997) Intense calling behavior is considered a measure 
of anxiety in the young of some species.  The excessive calling behavior of isolated 
domestic chicks has been shown to be diminished following injection of oxytocin 
(Panksepp, Nelson & Bekkedal, 1997).  In rat pups, separation cries were inhibited by 
central treatment with oxytocin (Insel & Winslow, 1991; Winslow & Insel, 1993). These 
examples suggest that oxytocin has anxiety reducing effects by way of both central and 
peripheral administration.  
Male mice that were exposed to a pharmacologically validated preclinical model 
of anxiety, the four-plate test (FPT), were found to display behavior that indicated the 
anxiolytic-like effect of oxytocin as well. The four-plate apparatus consists of a Plexiglas 
chamber with a floor made of four identical metal plates.  The plates are separated by a 
small gap (4mm) and electric shocks can be delivered through the metal plates. Foot 
shocks were delivered to the mice to suppress their exploration.  If the mouse crossed 
from plate to plate despite the shocks given with each crossing, the number of shocks 
administered were recorded as “punished crossings”.  Both peripheral and central 
administration of oxytocin produced dose-dependent increases in punished crossings 
(Ring, et al 2006). This particular experiment explored the anxiolytic-like effects of 
oxytocin, but perhaps, the oxytocin was also having an analgesic or antinociceptive effect 
causing the shock to be less painful or disruptive.  
Oxytocin is also known for its anxiolytic-like effects in sexual intercourse.  Thirty 
minutes after intercourse, male rats typically show increased time in the open arms of an 
elevated plus maze. Increased open-arm exploration (percentage of time spent on, and 
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number of entries into, open arms) indicates reduced anxiety.  Central administration of 
an oxytocin receptor antagonist immediately after mating reduced the open-arm 
exploratory behavior of the male rats. Administration of this antagonist had no effect on 
anxiety-related behavior in nonmated rats, suggesting that an up-regulation of the 
oxytocin-system is responsible for the anxiolytic effect of mating (Waldherr & Neumann, 
2007).  
Anti-inflammatory properties of oxytocin 
Oxytocin has antisecretory and antiulcer effects, facilitates wound healing and is 
involved in immune and inflammatory processes (Işeri, Gedik, Erzik, Uslu, Arbak et al, 
2008).  It can act as an anti-inflammatory and may also produce antinocicpetive effects 
due to its anti-inflammatory properties. These properties have been shown to be 
comparable to dexamethasone, a powerful anti-inflammatory (Petersson, Wiberg, 
Lundeberg &Uvnäs-Moberg, 2001). Some of the anti-inflammatory effects of oxytocin 
have been reported to be mediated through the inhibition of neutrophil-dependent 
oxidative damage (Işeri, Sener, Sağlam, Gedik et al., 2005). 
The latex of the Calotropis procera plant produces inflammation of the skin and 
mucous membranes. In one particular study (Padhy & Kumar, 2005), aqueous extracts of 
dried latex of C procera or carrageenan were injected into the subplantar surface of a rat 
paw 30 minutes after the subcutaneous administration of oxytocin.  The resulting 
hyperalgesic response and functional impairment were evaluated during a 24 hour period.  
Oxytocin produced a dose-dependent decrease at 1mg/kg in edema formation by the dried 
latex and carrageenan, with a 32% and 40% inhibition, respectively. At 0.1mg/kg there 
was no significant effect. Oxytocin was fairly effective in ameliorating inflammatory 
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hyperalgesia. Its anti-nociceptive effects persisted up to 24 hours after exposure to the 
irritant.  A mobility test (assessment of the animal’s locomotor ability) showed that 
oxytocin prevented impairment; the pup was able to move about with limited difficulty.  
In a stair climbing test (assessment of the pup’s ability to climb up three stairs of 
increasing height), treatment of oxytocin produced improvement in the task with dried 
latex as well as carrageenan-induced inflammatory hyperalgesia.  The effect of oxytocin 
was more pronounced in the case of carrageenan. 
  In rats, intraperitoneal oxytocin was found to improve renal function in tissue 
cultures. The rats were treated with oxytocin and later underwent a nephrectomy in which 
the kidneys were removed for tissue cultures. The oxytocin protected the renal tissue 
against ischemia/ reperfusion-induced oxidative damage through its anti-inflammatory 
action (Tuğtepe, Sener, Biyikli, Yüksel et al., 2007).   Oxytocin provided a therapeutic 
benefit by reducing the release of inflammatory cytokines, such as IL-1 and IL-6.  
Interim Summary 
Oxytocin is a neuropeptide involved in prosocial behaviors.  It is hypothesized to 
be secreted endogenously in young animals either in the presence of, or contact with, 
their mother. This peptide is also capable of reducing the activity of the HPA axis and has 
anxiolytic-like properties, which include reducing the calling of distressed infants. Its 
protective role as an anti-inflammatory may shield body tissues from damage. All of 
these effects are thought to be initiated through oxytocin’s natural endogenous release. 
Maternal Separation 
Maternal separation can be an extremely stressful situation for the young of many 
species. If placed alone in a novel environment, infants of several species exhibit HPA 
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activation and distinct behavioral changes (Rosenblum & Plimpton, 1981; Hennessy et 
al., 2001). In most species maternal separation produces an immediate increase in active 
behaviors, especially vocalizing.  In some species of primates this is followed by a 
passive stage characterized by reduced vocalizing and locomotor activity, together with 
reduced responsiveness and overall activity and the occurrence of slouched or hunched 
postures.  Studies with primates are of particular interest because primates display a 
specific emotional attachment to the mother that appears to mimic human attachment 
(Harlow, 1958).  
The Guinea Pig Model 
  The guinea pig is a highly social rodent that has been found to display evidence 
of standard criteria used to define attachment in primates and humans.  These include: 
recognition of and preference for the rearing figure as well as distressful reaction upon 
involuntary separation (Carter & Marr, 1970; Hennessy & Ritchey, 1987; Herman & 
Panksepp, 1978).  Many similarities have been documented in the response of guinea pig 
pups and species of primate infants to brief maternal separation (Hennessy, 2003).  When 
isolated, guinea pig pups exhibit HPA activation which, as in some primates is 
accompanied by an initial active, and subsequent passive, stage of behavioral 
responsiveness. 
The active behaviors, vocalization and locomotor activity, are typically displayed 
immediately following separation. The pups emit high-pitched vocalizations thought to 
be contact calls (Hennessy & Moorman, 1989). These vocalizations  also appear to reflect 
a heightened anxiety-like state since studies have shown that administration of anxiolytic 
drugs selectively reduce this particular behavior (Molewijk, Hartog, Van der Poel, Mos & 
 
 
10 
Olivier, 1996).  If the pup remains isolated in a novel environment for about an hour or 
more, active behavioral responses wane and the animal begins displaying a constellation 
of passive responses, notably a characteristic crouched stance, prolonged closure of the 
eyes, and extensive piloerection. These passive responses appear to be governed by pro-
inflammatory factors, such as cytokines, acting in the CNS.  Pups that were given 
lipopolysacchride (LPS), a promoter of inflammatory responses, displayed the same 
constellation of passive behavioral effects as prolonged isolation from the mother 
typically elicits (Hennessy et al, 2004).  Further, these specific behavioral responses have 
been shown to be reduced with anti-inflammatory administration (Schiml-Webb, Deak, 
Greenlee, Maken, & Hennessy, 2006).  These passive responses appear specific to the 
absence of the mother because placing the pup into the test cage with the mother fully 
blocks these responses, whereas the presence of an unfamiliar adult female did not 
(Hennessy & Morris, 2005).  
Hypotheses 
The presence of the mother may be able to cause the release of oxytocin in her 
pups, which in turn may have stress-reducing effects on her young. These might include 
an ability to reduce HPA activity as well as, active (anxiogenic) and passive (pro-
inflammatory mediated) behaviors. To test this hypothesis, we administered oxytocin to 
female guinea pig pups isolated from the mother. Only females were used in this study 
because oxytocin often has a greater impact on females than it does on males (Cho et al, 
1999).   In this exploratory study, oxytocin was administered to pups both peripherally 
(via injection) and centrally (via ICV infusion) because both routes of administration 
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were effective in previous studies.  Isolation behavior was monitored and blood samples 
were taken for analysis of HPA activity via cortisol assays.  
General methods 
 
Subjects 
 Female albino guinea pigs (Cavia porcellus) of the Hartley strain were bred in our 
laboratory and housed with their mothers and littermates.  They remained in plastic cages 
(75cm x 54cm x 24cm) filled with sawdust bedding located in our laboratory colony 
room.  Their diets consisted of water and guinea pig chow which were always freely 
available.  The lights in the colony room were maintained on a 12:12 light/dark cycle 
with lights on at 7:00 am and out at 7:00 pm.  The testing rooms and colony rooms were 
maintained between 65 and 70 ˚ F. All of the procedures used were approved by the 
Wright State University Laboratory Animal Care and Use Committee. 
ICV surgery  
Pups (≥ 190g) underwent surgery for placement of a cannula aimed at the right 
lateral ventricle between days 16 and 19 under isoflurane anesthesia with additional local 
anesthesia to the scalp (0.25mg/0.1ml 0.25% bupivicaine).  Guide cannulae (26 gauge) 
were placed relative to bregma with coordinates of -3.0mm anterior-posterior, -3.0 
medial-lateral, and -4.0mm dorsal-ventral, and a stainless steel screw was placed adjacent 
to the guide cannulae to help secure the cranioplastic cement.  All cannula supplies were 
sterile at the time of surgery and were purchased from Plastics One (Roanoke, VA).  All 
pups were treated with buprenorphine (0.015mg/0.05ml) post-surgery to control for pain.  
Following surgery animals were weighed daily and dummy cannulae were checked for 
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patency.  Animals were allowed to recover from surgery for at least 4 days prior to the 
first test.  
Drug Administration 
 Each pup was tested twice, once with a vehicle solution and once with a particular 
dose of oxytocin (Bachem Laboratories). The oxytocin doses were prepared in our 
laboratory and both the oxytocin and the vehicle solution were kept at -80˚ C until just 
prior to injection or central infusion.  Typically, no more than one pup per litter was used 
in an experimental group; however, there were a few exceptions in Experiment 2 where 
more than one pup per litter received the same dose of oxytocin. For peripheral 
administration, pups were removed from their home cages and injected subcutaneously in 
the nape of the neck with oxytocin or saline.  Once injected, the pup was returned to the 
home cage for 20 minutes prior to testing. For central administration, pups were removed 
from their home cages and infused (1µl/ 30 seconds) with 5µl of artificial cerebrospinal 
fluid (aCSF) vehicle, or oxytocin in aCSF vehicle with a Hamilton microsyringe. The tip 
remained in place for an additional 30 seconds to ensure all the fluid was administered.  
Once infused, the pup was returned to the home cage for 20 minutes prior to testing. 
Test Procedures 
For testing, the pup was taken in a carrying cage to the test room and placed in a 
transparent, plastic testing cage (47cm x 24cm x 20cm) with a clear vented lid.  The test 
room was kept approximately at 67°F.  If the testing room is found to be below 65°F, a 
space heater was used to adjust the temperature before testing began. 
 A pup’s first test took place between days 19-22 (with day 0 being the day of 
birth), and the second between days 23-26 with a minimum of three days between 
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behavior tests.   The order in which oxytocin and the vehicle were administered was 
counterbalanced across pups. Pups were exposed alone to the test cage for three hours, 
with behavior observed at 0-30, 60-90, and 150-180 minutes.  The pup’s two tests always 
started at the same time of day; 10:00 am-1:00 pm, 10:30 am-1:30 pm, 12:00 pm-3:00 
pm, 12:30 pm-3:30 pm, or 4:00 pm-7:00 pm.  
Behavioral observation 
Active and passive separation behaviors were scored by a trained observer 
through one way glass. The behaviors noted, with pencil and paper, included: 
vocalizations, line crossings, crouch, eye closure, and piloerection.  A microphone 
situated above the test cage was used to transmit vocalizations to a headphone worn by 
the observer.  “Whistle” vocalizations were tallied on a hand counter. Locomotor activity 
was measured by the number of times the pup crossed any of four lines dividing the 
testing cage into four equal sections.  Whereas vocalizing and line-crossing (the active 
behaviors) were scored continuously, one-zero sampling was used for the passive 
responses (crouch, eye closure, piloerection), which tended to occur over prolonged 
periods of time. The number of 60-s intervals in which the animal displayed the crouched 
stance (body hunched down with head lowered and feet tucked beneath), eye-closing 
(more than 1 s of sustained complete closure or near-complete closure of one eye or both 
eyes), and extensive piloerection (occurring over most of the visible body surface) was 
scored (i.e., maximum score = 30 for each 30-min observation session). When all three of 
these passive behaviors are seen simultaneously, they are termed a “full passive 
response”. 
Blood sampling and cortisol determination 
 
 
14 
 Ear veins located along the periphery of the external ear were used to collect 
blood for cortisol analysis.  One experimenter held the pup on his or her lap while a 
second experimenter pricked the blood vessels with a 23g injection needle. The blood 
was collected in a capillary tube as the ear was massaged to increase blood flow.   
During the 3- hour separation period, blood samples were taken after 30 minutes, 
90 minutes, and 180 minutes. Blood samples for estimates of resting levels were 
collected at the same time of day at least 24 hours after the first, and 24 hours before the 
second, isolation tests.   The blood samples were collected within 5 minutes of the 
initiation of disturbance.  This is rapidly enough to ensure cortisol levels in the samples 
obtained were not affected by its sampling procedure (Sachser, 1994).  The blood was 
centrifuged and the plasma was separated and frozen until the time of assay.  Cortisol 
concentrations were determined in duplicate using a standard radioimmunoassay kit (125I 
‘Coat-a-Count’ Cortisol, Diagnostic Products, Los Angeles, CA).  Intra- and inter- assay 
coefficients of variation were 8.9% and 3.2%, respectively. 
Data Analyses 
 Because of large numbers of zero scores and otherwise nonnormal distributions of 
nearly all measures, and for consistency and ease of presentation, nonparametric tests 
were used for all behavior analyses, and central tendency and variability are represented 
by medians and semi-interquartile ranges. Cortisol levels were assessed with analysis of 
variance (ANOVA) or t-test, with central tendency and variability represented with 
means and standard errors.  Because some animals did not provide complete data 
(primarily due to an inability to collect sufficient blood) sample sizes varied from 9 to 18 
for different measures. 
 
 
15 
Experiment 1 
 To test the behavioral and physiological effects of peripheral injection of oxytocin 
in isolated guinea pig pups, oxytocin was injected subcutaneously.  
Method 
Each pup was tested once with a saline solution and once with a 10µg dose of 
oxytocin in a volume of .2 ml. This dose of oxytocin was chosen because it has been 
found to have behavioral effects in rodents of similar size to guinea pig pups (Witt, Carter 
& Walton, 1990). 
Results 
Cortisol.  The repeated measures ANOVA showed a significant Drug X Time 
interaction, F (2, 16) = 5.71.  Follow- up simple main effects tests revealed that 
subcutaneous injection of 10µg oxytocin significantly reduced the levels of plasma 
cortisol in isolated female guinea pig pups at 180 minutes compared to the vehicle saline, 
p < 0.01.  There was no significant effect at either the 30 or 90 minute time points.  
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Fig.1. Mean plasma cortisol levels and standard errors (vertical lines) of female guinea pig pups (N=9) in 
the base (0 min) condition and 30, 90 and 180-min following exposure to the novel environment in the 
oxytocin and saline conditions.  
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Active Behaviors. The Wilcoxon test showed that the administration of oxytocin 
did not significantly affect the active behaviors (vocalization and line-crossing) in 
comparison to the vehicle in isolated guinea pig pups (N=15). The semi interquartile 
ranges (SIR) were greater than the median values for both groups, indicating a high 
degree of variability in scores.  
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Table 1 
Median and Semi-Interquartile Range (SIR)of Active Behaviors in Experiment 1 
  Oxytocin(10µg) Saline 
Vocalizations 
          Median 
                SIR 
50 
664 
258 
443 
Line-Crossings 
           Median  
                 SIR 
5 
9 
5 
23 
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Passive Behaviors.  The Wilcoxon test showed that pups exhibited a marginally 
significant decrease in crouching (p <0.08) and a significant reduction in eye closure (p 
<0.05) with the administration of oxytocin compared to those given the vehicle, saline.  
No difference was found for piloerection or the full passive response.   
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Fig.2. Median and semi interquartile range (SIR) number of crouch, eye-close, piloerection, and the full 
passive response observed in female guinea pig pups during 180-min isolation test in Experiment 1. 
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Discussion 
 
Oxytocin reduced plasma cortisol levels in isolated guinea pig pups at 180 
minutes of separation.   The active behaviors scored were not significantly affected. The 
vocalization values were numerically lower with administration of oxytocin as opposed 
to saline. However, the great variability of the scores was more striking. For example, of 
the 15 animals tested, the number of vocalizations documented ranged from 0 for some 
animals to thousands for others in the same condition. The passive behavior of eye 
closure was significantly reduced by oxytocin while crouch was marginally reduced.  The 
other two behaviors were not significantly different. It appears then that the oxytocin 
administration procedure used here had a small moderating influence on the passive 
response. 
Experiment 2 
In Experiment 1, one of the four passive behaviors  was significantly reduced and  
cortisol was found to be significantly lower at 180-min with the administration of 
oxytocin.  Therefore, it was thought that increasing the dose might enhance the effects of 
oxytocin.  Furthermore, because there was no sign of an effect of oxytocin on cortisol 
levels at 30 or 90-min, and because the disturbance of collecting these samples might 
have influenced behavior, Experiment 2 assessed cortisol responses only at the 180-min 
time point.  Both a 10 and 20µg dose were administered. 
Method 
Two groups of pups, one receiving 10µg dose and the other a 20µg dose, were 
each tested twice, once with oxytocin and once with saline, with blood samples collected 
only at 180 minutes to reduce disturbance. 
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Results 
 Cortisol.  A paired t-test of 180-min cortisol values showed that subcutaneous 
injection of either10µg (N= 18) or 20µg (N=14) oxytocin had no measurable effect on the 
cortisol response. 
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Fig.3. Mean resting plasma cortisol levels and levels at 180-min following oxytocin or saline injection in 
Experiment 2 
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Active Behaviors.  The Wilcoxon test revealed no significant differences in the 
number of vocalizations or line-crossings exhibited following administration of 10µg 
(N=18) or 20µg oxytocin (N=18) vs. saline in female guinea pig pups.  As in Experiment 
1, the semi-interquartile ranges indicate high variability in the data.  
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Table 2  
Median and Semi-Interquartile Range (SIR) of Active Behaviors in Experiment 2 
10µg       Oxytocin  Saline 
 
Vocalizations 
          Median 
                SIR 
    
925 
797 
  
389 
671 
 
 
Line-crossings 
Median  
SIR    
5 
29  
13 
12 
20µg        
 
Vocalizations 
Median 
SIR 
    
330 
945 
  
573 
867 
 
 
Line-crossings 
Median  
SIR     
10 
23  
3 
16 
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Passive Behaviors.  The Wilcoxon test revealed no significant difference for 
crouch, eye-close, piloerection, or the full passive response with administration of either 
10µg (N=18) or 20µg (N=18) oxytocin vs saline in guinea pig pups. 
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Fig.4. Median and semi interquartile range (SIR) number of crouch, eye-close, piloerection, and the full 
passive response observed in female guinea pig pups during 180-min isolation test in Experiment 2 
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Discussion 
 
This experiment was quite similar to the first, but did not reveal any significant 
effects.  The only differences between the two experiments were the addition of a second 
dose of oxytocin, 20µg, and the elimination of two blood samples (at 30 and 90-min). 
The first two blood samples were eliminated in Experiment 2 in order to reduce 
disturbance of the pup, which was thought to possibly reduce measurable effects of 
oxytocin.  Instead the results suggest that the disturbance may have enhanced oxytocin’s 
effects. 
Experiment 3 
 In Experiments 1 and 2 oxytocin was administered via peripheral injection. In this 
experiment, oxytocin was administered centrally through an intracerebroventricular 
(ICV) cannula.  Oxytocin has limited permeability through the blood brain barrier; 
therefore, central administration of oxytocin guarantees its presence within the brain. 
Method  
A 1µg dose of oxytocin was chosen because this is a commonly used dose in 
rodents of the approximate size of guinea pig pups (Cho, et al., 1999). Initially, blood 
samples were taken three times on the testing day: 30, 90 and 180-minutes following 
isolation.  A preliminary analysis of subjects indicated that no differences were apparent 
at 90 minutes and so this sample was omitted in tests of later tested pups to minimize 
disturbance. There was no difference in the response of pups that did and did not have 
blood collected at 90-min, and so data for the two subgroups were combined. Following 
the last behavior test, all pups were euthanized and the correct placement of the cannula 
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was confirmed by injecting dye into the cannula.  Only pups found to have dye in the 
lateral ventricle(s) were included in analyses.  
Results 
Cortisol. The repeated measures ANOVA displayed a marginally significant Drug 
X Time interaction, F (1, 11) = 4.11, p < 0.07, N= 12.  A planned comparison of the 30 
min value showed that oxytocin significantly reduced the levels of circulating cortisol in 
pups compared to those who received aCSF, p< 0.04). In addition, there was a significant 
effect of Time, F (1, 11) = 7.65, p < 0.02, with levels overall increasing from 30 to 180 
min. 
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Fig.5. Mean basal plasma cortisol levels and levels at 30-min and 180-min following infusion of oxytocin 
or aCSF in Experiment 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
Active Behaviors.  There was no significant difference in the number of 
vocalizations or line-crossings exhibited with the central administration of 1µg oxytocin 
vs aCSF in guinea pig pups (N=12). As in Experiments 1 and 2, the semi-interquartile 
ranges indicated that scores were very variable. 
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Table 3 
Median and Semi-Interquartile Range (SIR) of Active Behaviors in Experiment 3 
  Oxytocin(1µg) aCSF 
Vocalizations 
          Median  
                SIR 
33 
88 
41 
467 
Line-Crossings 
           Median  
                 SIR 
14 
30 
7 
92 
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Passive Behaviors.  The Wilcoxon test revealed no significant effect for crouch, 
eye-close, piloerection, or the full passive response with the central administration of 1µg 
oxytocin vs aCSF in guinea pig pups (N=12). Still, the median values for all three 
individual passive behaviors following oxytocin administration are nearly half those 
following administration of aCSF.   
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Fig.6. Median and semi-interquartile range (SIR) number of crouch, eye-close, piloerection, and the full 
passive response observed in female guinea pig pups during 180-min isolation test in Experiment 3 
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Discussion 
A significant reduction in the circulating cortisol levels at 30-min following 
oxytocin administration was found, with levels overall increasing from 30-min to 180-
min.  The active behaviors were not significantly affected.   No significant differences 
were found for crouch, eye-closure, piloerection, or the full passive response behaviors.  
However, the median values for all three passive behaviors were nearly half those with 
administration of oxytocin. This suggests a tendency for this dose of oxytocin to have a 
slight effect on reducing passive behaviors. This suggestion would need to be tested in 
further experiments. 
General Discussion 
The presence of the mother has been shown to reduce the activity of the HPA axis 
in her pups when exposed to a novel environment.  Oxytocin is hypothesized to be 
released in the young of several species in the presence of their mother. At 180-min of 
separation in Experiment 1, oxytocin reduced plasma cortisol levels in isolated guinea pig 
pups. This mimics the effect that the presence of an attachment figure has and is 
consistent with the idea that oxytocin may be involved in the mother’s ability to reduce 
HPA activity in her pups. However, the cortisol effect seen in the first experiment was 
not found in the second.  The only differences between the two experiments were the 
addition of a second dose of oxytocin, 20µg, and the elimination of two blood samples. 
Because the 10µg dose did not produce a decline in cortisol levels as it had in Experiment 
1, the added disturbance of the two additional blood samples in Experiment 1 may have 
contributed to the difference in findings between these two experiments. Oxytocin release 
is typically elicited with somatosensory stimulation.  Because the pups in the first 
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experiment were handled more than those in the second, the added disturbance may 
actually have intensified the effect of oxytocin.   
Another difference in the outcomes of Experiment 1 and 2 was that there was 
some reduction of passive responses with oxytocin in Experiment 1 but not Experiment 2. 
These passive responses are thought to be mediated by proinflammatory factors since 
administration of an anti-inflammatory has been shown to reduce these specific 
behaviors. Oxytocin is believed to have anti-inflammatory properties; a protective effect 
that may buffer the action of substances such as cytokines.  However, data from this 
study suggests that oxytocin may only display anti-inflammatory action under certain 
conditions. In Experiment 1 only one passive behavior was significantly reduced with 
oxytocin administration and none were in Experiment 2. Yet, there was some tendency 
for the oxytocin condition to result in lower values of passive behaviors in both 
experiments. 
Neither Experiment 1 nor 2 found significant effects on active behavior.  The 
variability in these data may have contributed to the lack of significance. Oxytocin has 
been suggested to have anxiolytic-like effects in some animals; still, these effects may 
only be seen under certain testing conditions. 
In Experiment 3, there was a significant reduction in the circulating cortisol levels 
at 30-min with oxytocin administration.  The oxytocin was present in the CNS 
immediately upon infusion which may account for the effect being displayed after a short 
period of isolation.  Central infusion of any substance ensures that the BBB has been 
traversed and the compound can act within the CNS.  This suppression of the cortisol 
response was not present at 180-min.  
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No significant differences were found for crouch, eye-close, piloerection, or the 
full passive response with the central administration of 1µg oxytocin.  However, the 
median values for all three individual passive behaviors were nearly half those with 
administration of oxytocin. This suggests a tendency for oxytocin to reduce the passive 
behaviors. Once again, there was no significant effect on the active behaviors. 
Peripherally, oxytocin is best known for its hormonal actions during labor and 
lactation.  Within the CNS its actions promote prosocial behaviors such as infant-mother 
attachment. The effects of centrally and peripherally administered oxytocin are different, 
but there is evidence that both play an important role in reducing the stress response.  In 
this study, some aspects of oxytocin’s capability to reduce responses to stress were 
revealed.  The effect of central administration on behavior is more easily understood 
because the full dose of oxytocin is administered directly to the brain, whereas 
peripherally administered oxytocin must somehow exert action beyond the blood brain 
barrier.  Both peripheral and central administration of oxytocin significantly reduced 
plasma cortisol levels at different time points of isolation. Oxytocin administered 
peripherally reduced the duration rather than the magnitude of the cortisol response. Data 
in this study suggest that oxytocin administered peripherally may take a longer time to 
influence the HPA axis.  Peripheral administration of oxytocin also significantly reduced 
eye closure, a passive behavior; still, with both routes of administration oxytocin 
displayed a tendency toward the reduction of passive behavior. 
 The half-life of oxytocin is minutes; small doses degrade more quickly than 
larger doses. One µg is a typical dose used for central infusion in rodents; yet larger doses 
may produce more significant results.  Future studies might examine the effect of a larger 
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dose on active and passive behaviors.  In addition, future studies should examine the 
route by which peripherally administered oxytocin produces its effects.  Action on 
plasma cortisol levels could be exerted either centrally or peripherally at the level of the 
adrenal.  How peripheral injection of the peptide might affect behavior is less clear.  In 
summary, the present three experiments offer some, though limited, support for the 
hypothesis.  
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